| Management of Helicobacter pylori infection—the Maastricht V/Florence consensus report P Malfertheiner, F Mégraud, CA O'Morain, JP Gisbert, EJ Kuipers, ... Gut 66 (1), 6-30, 2017 | 4564* | 2017 |
| What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases E Rinninella, P Raoul, M Cintoni, F Franceschi, GAD Miggiano, ... Microorganisms 7 (1), 14, 2019 | 4267 | 2019 |
| Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report P Malfertheiner, F Megraud, T Rokkas, JP Gisbert, JM Liou, C Schulz, ... Gut 71 (9), 1724-1762, 2022 | 1732 | 2022 |
| European consensus conference on faecal microbiota transplantation in clinical practice G Cammarota, G Ianiro, H Tilg, M Rajilić-Stojanović, P Kump, R Satokari, ... Gut 66 (4), 569-580, 2017 | 1446 | 2017 |
| Proteobacteria: a common factor in human diseases G Rizzatti, LR Lopetuso, G Gibiino, C Binda, A Gasbarrini BioMed research international 2017 (1), 9351507, 2017 | 1356 | 2017 |
| Statements from the Taormina expert meeting on occult hepatitis B virus infection G Raimondo, JP Allain, MR Brunetto, MA Buendia, DS Chen, M Colombo, ... Journal of hepatology 49 (4), 652-657, 2008 | 1184 | 2008 |
| Commensal Clostridia: leading players in the maintenance of gut homeostasis LR Lopetuso, F Scaldaferri, V Petito, A Gasbarrini Gut pathogens 5 (1), 23, 2013 | 1011 | 2013 |
| Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota W Fusco, MB Lorenzo, M Cintoni, S Porcari, E Rinninella, F Kaitsas, ... Nutrients 15 (9), 2211, 2023 | 987 | 2023 |
| Actinobacteria: A relevant minority for the maintenance of gut homeostasis C Binda, LR Lopetuso, G Rizzatti, G Gibiino, V Cennamo, A Gasbarrini Digestive and Liver Disease 50 (5), 421-428, 2018 | 880 | 2018 |
| Food components and dietary habits: keys for a healthy gut microbiota composition E Rinninella, M Cintoni, P Raoul, LR Lopetuso, F Scaldaferri, G Pulcini, ... Nutrients 11 (10), 2393, 2019 | 830 | 2019 |
| Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori A Gasbarrini, F Franceschi, R Tartaglione, R Landolfi, P Pola, ... The Lancet 352 (9131), 878, 1998 | 810 | 1998 |
| Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection G Cammarota, L Masucci, G Ianiro, S Bibbò, G Dinoi, G Costamagna, ... Alimentary pharmacology & therapeutics 41 (9), 835-843, 2015 | 766 | 2015 |
| Antibiotics as deep modulators of gut microbiota: between good and evil G Ianiro, H Tilg, A Gasbarrini Gut 65 (11), 1906-1915, 2016 | 751 | 2016 |
| Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute‐on‐chronic liver failure: the RELIEF trial R Bañares, F Nevens, FS Larsen, R Jalan, A Albillos, M Dollinger, ... Hepatology 57 (3), 1153-1162, 2013 | 726 | 2013 |
| Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease FR Ponziani, S Bhoori, C Castelli, L Putignani, L Rivoltini, F Del Chierico, ... Hepatology 69 (1), 107-120, 2019 | 717 | 2019 |
| Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis MA Zocco, LZ Dal Verme, F Cremonini, AC Piscaglia, EC Nista, ... Alimentary pharmacology & therapeutics 23 (11), 1567-1574, 2006 | 696 | 2006 |
| Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study A Santoro, L Rimassa, I Borbath, B Daniele, S Salvagni, JL Van Laethem, ... The lancet oncology 14 (1), 55-63, 2013 | 685 | 2013 |
| Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study S Qin, SL Chan, S Gu, Y Bai, Z Ren, X Lin, Z Chen, W Jia, Y Jin, Y Guo, ... The Lancet 402 (10408), 1133-1146, 2023 | 671 | 2023 |
| Meta‐analysis: the effect of probiotic administration on antibiotic‐associated diarrhoea F Cremonini, S Di Caro, EC Nista, F Bartolozzi, G Capelli, G Gasbarrini, ... Alimentary pharmacology & therapeutics 16 (8), 1461-1467, 2002 | 657 | 2002 |
| Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL# 3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo … A Tursi, G Brandimarte, A Papa, A Giglio, W Elisei, GM Giorgetti, G Forti, ... Official journal of the American College of Gastroenterology| ACG 105 (10 …, 2010 | 646 | 2010 |
Giovanni CammarotaProfessore Ordinario, Gastroenterologia, Fondazione Policlinico Universitario A. Gemelli, Roma,Verified email at unicatt.it
